Related Experiment Videos
Statin therapy in the elderly: a review.
Iwona Szadkowska1, Adam Stanczyk, Wilbert S Aronow
1Department of Internal Diseases and Cardiological Rehabilitation, Medical University of Lodz, Hallera Sq. 1, 90-647 Lodz, Poland. iwonakoska@interia.pl
Archives of Gerontology and Geriatrics
|February 17, 2009
Summary
Statins effectively lower cholesterol and improve outcomes in older adults, a group often excluded from trials despite high cardiovascular risk. Evidence supports their use for managing hypercholesterolemia in the elderly.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Cardiovascular morbidity is the primary cause of death in developed countries.
- Elevated serum cholesterol is a significant risk factor for ischemic heart disease, particularly in older adults.
- Older adults with hypercholesterolemia are a major modifiable risk group but are often underrepresented in clinical trials.
Purpose of the Study:
- To review the evidence for the efficacy and safety of statin use in older adults.
- To address the underutilization of statins in elderly populations at high cardiovascular risk.
- To examine the benefits of cholesterol lowering in the aging demographic.
Main Methods:
- Systematic review of recent clinical trials and relevant literature.
- Analysis of data focusing on cardiovascular risk reduction in elderly patients.
- Evaluation of statin effectiveness in managing hypercholesterolemia in older adults.
Main Results:
- Recent trials suggest elderly patients with the highest cardiovascular risk benefit most from statin therapy.
- Statins are effective in reducing serum cholesterol levels in older adults.
- Despite benefits, statins may be underused in this population.
Conclusions:
- The aging population necessitates increased attention to hypercholesterolemia management in older adults.
- Statins offer significant cardiovascular benefits for elderly individuals.
- Further research and clinical practice should prioritize statin use in high-risk older adults.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...